ANI Pharmaceuticals Reports Third Quarter and Year-To-Date 2018 Results and Reaffirms Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/7/2026

1. MU
2. APTX:CN
3. SPY
4. SPCX
5. IQMX
6. MSTR
7. EROC
8. SEER
9. NVDA
10. RIVN

Go back to ANI Pharmaceuticals Reports Third Quarter and Year-To-Date 2018 Results and Reaffirms Guidance

ANI Pharma (ANIP) Tops Q3 EPS by 12c, Reaffirms Guidance

November 6, 2018 8:35 AM EST

ANI Pharma (NASDAQ: ANIP) reported Q3 EPS of $1.29, $0.12 better than the analyst estimate of $1.17. Revenue for the quarter came in at $50.7 million versus the consensus estimate of $50.96 million.

GUIDANCE:

ANI Pharma sees FY2018 EPS of $4.80-$5.27, versus the consensus... More